#Japan #Tokyo #liver cancer #Health Awareness #Tokyo Medical

7th Tokyo Medical Research Citizen Lecture: Understanding Liver Health

The Tokyo Medical Research Institute is set to host its seventh public lecture on February 10, 2026, from 2:30 PM to 4:00 PM. This hybrid event will feature presentations from esteemed experts focused on liver health, particularly in relation to liver cancer prevention. The title of the event is "Is Your Liver Healthy? Aiming to Eradicate Liver Cancer".

The Tokyo Medical Research Institute conducts comprehensive research on critical yet often poorly understood diseases, including neurological disorders, mental illnesses, cancer, and infectious diseases. The goal of these annual lectures is to communicate research findings and health information to the citizens of Tokyo in an accessible manner. This year's featured speaker is Dr. Tetsuro Shimakami, an Associate Professor in Gastroenterology at Kanazawa University.

Event Highlights

• ---

Date and Time

• - When: February 10, 2026 (Tuesday), 2:30 PM - 4:00 PM
• - Mode: Hybrid (in-person and via Zoom)

Presentation Topics

• - Title: "Who is at Risk for Liver Cancer? Key Information for Prevention"

Speaker: Dr. Tetsuro Shimakami, Kanazawa University
Abstract: Liver cancer ranks as the fifth leading cause of cancer-related deaths, known as a major cancer due to its often silent nature. The primary risk factor for liver cancer is infection with Hepatitis B or C viruses. However, there has been a worrying increase in cases arising from non-viral conditions like fatty liver due to lifestyle factors like overeating and lack of exercise. With advancements in antiviral therapies, those with viral hepatitis can significantly lower their chances of developing liver cancer. This presentation will elucidate strategies to combat both viral and fatty liver conditions, emphasizing the power of knowledge and preventive measures in combating liver cancer.

• - Title: "C Hepatitis Virus Research: Past, Present, Future"

Speaker: Dr. Daisuke Yamane, Tokyo Medical Research Institute
Abstract: Developing antiviral treatments has relied heavily on establishing techniques for culturing the Hepatitis C virus, which has historically posed challenges. Despite recent advancements in highly effective antiviral medications, infections remain prevalent globally, with many unaware of their condition. Cases of liver cancer occurring after viral elimination present ongoing challenges in this field. This session will explore contemporary trends in liver disease and cutting-edge treatments, alongside updates on ongoing viral research initiatives.

Registration Details

The lecture is free and open to 600 participants, with 100 attending in person at the Tokyo Medical Research Institute Auditorium and 500 joining online. Registration is required on a first-come, first-served basis.

For In-Person Attendance

• - Application by Mail: Send a return postcard specifying "7th Citizen Lecture (In-Person)" with your name, address, age, and phone number, plus details for accompanying guests if applicable, to the address below:

Tokyo Medical Research Institute, Public Relations Office
2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506

• - Application by Email: Write to [email protected] with the subject "7th Citizen Lecture (In-Person)" along with your personal details.

For Online Participation

• - Register via the Tokyo Medical Research Institute website: Official Website

Deadline for Registration

• - In-Person: February 8, 2026
• - Online: Until the time of the lecture

Participants will earn 100 Tokyo points for attending and submitting feedback via an online questionnaire. For further details, please visit the official app site Tokyo App.

This event is a vital opportunity for citizens to improve their understanding of liver health and the preventive measures against liver cancer. Join us in this informative session to enhance your health awareness and contribute towards a cancer-free future!